Clinical Trials
Sponsor:
Sponsor Study ID:
Study Title:
A Phase 3, Randomized, Double Blind, Adaptive, Placebo/Paclitaxel Controlled Study of AVB S6 500 in Combination With Paclitaxel in Patients With Platinum Resistant Recurrent Ovarian Cancer
NCT Number:
NCT04729608
Phase:
II
Protocol Type:
Treatment
Age Group:
Adults
Disease Sites:
Ovary
Study Objectives:
This is a Phase 3 study of AVB-S6-500 in combination with paclitaxel (Pac) in patients with platinum resistant recurrent ovarian cancer. This is a randomized, double-blind, placebo-controlled study to compare efficacy and tolerability of AVB-S6-500 in combination with Pac versus placebo plus Pac.
Study Documents
(MUSC NetID required for document access)